Dual Targeted Therapy with p53 siRNA and Epigallocatechingallate in a Triple Negative Breast Cancer Cell Model (original) (raw)
Double gene siRNA knockdown of mutant p53 and TNF induces apoptosis in triple-negative breast cancer cells
Ioana Berindan Neagoe
OncoTargets and Therapy, 2016
View PDFchevron_right
Combining the chemotherapeutic effects of epigallocatechin 3-gallate with siRNA-mediated p53 knock-down results in synergic pro-apoptotic effects
Alexandru Irimie
International Journal of Nanomedicine, 2012
View PDFchevron_right
Targeting Cell Death Mechanism Specifically in Triple Negative Breast Cancer Cell Lines
Lavinia Pruteanu
International Journal of Molecular Sciences
View PDFchevron_right
Intracellular delivery of ERBB2 siRNA and p53 gene synergistically inhibits the growth of established tumor in an immunocompetent mouse
Ezharul Hoque Chowdhury
View PDFchevron_right
Epigallocatechin-3-Gallate (EGCG) Inhibits Cell Proliferation and Migratory Behaviour of Triple Negative Breast Cancer Cells
Ioana Berindan Neagoe
Journal of Nanoscience and Nanotechnology, 2013
View PDFchevron_right
Apoptosis of human fibrosarcoma HT-1080 cells by epigallocatechin-3-O-gallate via induction of p53 and caspases as well as suppression of Bcl-2 and phosphorylated nuclear factor-κB
Dong-Wook Han
Apoptosis, 2011
View PDFchevron_right
New perspectives in triple-negative breast cancer therapy based on treatments with TGFβ1 siRNA and doxorubicin
Livia Budişan
Molecular and Cellular Biochemistry, 2020
View PDFchevron_right
The Efficacy of siRNA Specific MDM2 in the Induction of Apoptosis in MCF-7 Breast Cancer Cell Line
Tahereh Kalantari
Middle East Journal of Cancer, 2021
View PDFchevron_right
The Role of Apoptotic Genes and Protein-Protein Interactions in Triple-negative Breast Cancer
Karam Soliman
Cancer Genomics & Proteomics, 2023
View PDFchevron_right
p53 siRNA - a therapeutic tool with significant implication in modulation of apoptosis and angiogenic pathways
Cornelia Braicu
Clujul Medical, 2015
View PDFchevron_right
Epigallocatechin-3-gallate induces apoptosis and cell cycle arrest in HTLV-1-positive and -negative leukemia cells
Steve Harakeh
Medical Oncology, 2007
View PDFchevron_right
Estrogen receptor prevents p53-dependent apoptosis in breast cancer
Myles Brown, Shannon Bailey
Proceedings of the National Academy of Sciences, 2012
View PDFchevron_right
Epigenetics of Triple-negative Breast Cancer via Natural Compounds
Fahad Al-abbasi, Wasim Ahmad, Mohammad Kaleem Khan
Bentham Science Publishers, 2021
View PDFchevron_right
Estrogen Receptor Inhibits p53-Mediated Transcriptional Repression: Implications for the Regulation of Apoptosis
Fengzhi Li
Cancer Research, 2007
View PDFchevron_right
Normal breast epithelial cells induce p53-dependent apoptosis and p53-independent cell cycle arrest of breast cancer cells
Robert-alain Toillon
Breast Cancer Research and Treatment, 2002
View PDFchevron_right
Inhibition of NF-κB-mediated transcription and induction of apoptosis in human breast cancer cells by epoxypseudoisoeugenol-2-methyl butyrate
Nese Kirimer
Cancer Chemotherapy and Pharmacology, 2009
View PDFchevron_right
Bioengineered siRNA-Based Nanoplatforms Targeting Molecular Signaling Pathways for the Treatment of Triple Negative Breast Cancer: Preclinical and Clinical Advancements
Dima Hattab
Pharmaceutics, 2020
View PDFchevron_right
Signaling Pathways and Natural Compounds in Triple-Negative Breast Cancer Cell Line
citra dewi
Molecules
View PDFchevron_right
High Efficiency Apoptosis Induction in Breast Cancer Cell Lines by MLN4924/2DG Co-Treatment
alireza farajollahi
Asian Pacific journal of cancer prevention : APJCP, 2015
View PDFchevron_right
Inhibition of NF-kappaB-mediated transcription and induction of apoptosis in human breast cancer cells by epoxypseudoisoeugenol-2-methyl butyrate
K. Husnu C Baser
Cancer chemotherapy and pharmacology, 2009
View PDFchevron_right
Triple-negative breast cancer: investigating potential molecular therapeutic target
Luigi Rossi
Expert Opinion on Therapeutic Targets, 2015
View PDFchevron_right
Induction of p53 up-regulated modulator of apoptosis messenger RNA by chemotherapeutic treatment of locally advanced breast cancer
Adolfo Fuentes
Clinical Cancer Research, 2005
View PDFchevron_right
P53 and its molecular basis to chemoresistance in breast cancer
Per Lønning
Expert Opinion on Therapeutic Targets, 2012
View PDFchevron_right
Targeting mutant p53 protein and the tumor vasculature: an effective combination therapy for advanced breast tumors
Yayun Liang
Breast Cancer Research and Treatment, 2011
View PDFchevron_right
EGCG down-regulates telomerase in human breast carcinoma MCF-7 cells, leading to suppression of cell viability and induction of apoptosis
Mitchell Pate
International Journal of Oncology, 2004
View PDFchevron_right
Suppression of p53R2 gene expression with specific siRNA sensitizes HepG2 cells to doxorubicin
Yasin Ahmadi
Gene, 2017
View PDFchevron_right
Differential gene expression in p53-mediated apoptosis-resistant vs. apoptosis-sensitive tumor cell lines
Steve Maxwell
… of Sciences of the United States …, 2000
View PDFchevron_right